Flagship Pioneering Fund VI, L.P.'s Net Worth
$212 Million
Who is Flagship Pioneering Fund VI, L.P.?
Flagship Pioneering Fund VI, L.P. has an estimated net worth of $212 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Omega Therapeutics, Inc., and Seres Therapeutics, Inc..
SEC CIK
Flagship Pioneering Fund VI, L.P.'s CIK is 0001716926
Past Insider Trading and Trends
2021 was Flagship Pioneering Fund VI, L.P.'s most active year for acquiring shares with 13 total transactions. Flagship Pioneering Fund VI, L.P.'s most active month to acquire stocks was the month of July. 2021 was Flagship Pioneering Fund VI, L.P.'s most active year for disposing of shares, totalling 15 transactions. Flagship Pioneering Fund VI, L.P.'s most active month to dispose stocks was the month of July. 2021 saw Flagship Pioneering Fund VI, L.P. paying a total of $19,999,973.00 for 57,944,228 shares, this is the most they've acquired in one year. In 2021 Flagship Pioneering Fund VI, L.P. cashed out on 119,347,583 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $6.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.03% | -11.78M |
—
|
—
| 25M |
Sep 13
| |||
Form 4
|
∞
| 34.24M |
—
|
—
| 34.24M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 23.71M |
$17.00 |
—
| 23.71M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.0315
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.84% | -7.91M |
—
|
—
| 11.94M |
Nov 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |